Literature DB >> 8280057

Reaction of proteasomes with peptidylchloromethanes and peptidyldiazomethanes.

P J Savory1, H Djaballah, H Angliker, E Shaw, A J Rivett.   

Abstract

The multicatalytic endopeptidase complex (proteasome) has multiple distinct peptidase activities. These activities have often been referred to as 'chymotrypsin-like', 'trypsin-like' and 'peptidylglutamyl-peptide hydrolase' activities according to the type of residue in the P1 position, although it is now clear that mammalian proteasomes have at least five distinct catalytic sites. In the present study, potential affinity-labelling reagents (peptidylchloromethanes, peptidyldiazomethanes, a peptidylfluoromethane and peptidylsulphonium salts) containing hydrophobic, basic or acidic amino acid residues in the P1 position have been tested for inhibition of the different activities of the rat liver proteinase complex. The results show that individual peptidase activities of proteasomes can be inhibited by a variety of peptidylchloromethanes and peptidyldiazomethanes. Although the rate of inactivation of proteasomes by even the most effective peptidylchloromethanes and peptidyldiazomethanes are often quite slow (k(obs)/[I] in the range 0.1-10 M-1 x s-1) compared with the reaction of similar compounds with some other proteinases, the results provide useful information concerning the specificity of the distinct catalytic centres of proteasomes, and some selective affinity-labelling reagents have been identified. Tyr-Gly-Arg-chloromethane was found to be a useful inhibitor of trypsin-like activity. Inhibition of the other peptidase activities was often incomplete, even after repeated addition of inhibitor, and it proved to be difficult to predict the effect of different reagents. For example, Cbz-Tyr-Ala-Glu-chloromethane was found to inhibit 'chymotrypsin-like' activity (assayed with Ala-Ala-Phe-7-amino-4-methylcoumarin or succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin), while the best inhibitors of 'peptidylglutamyl-peptide hydrolase' activities (assayed with benzyloxycarbonyl-Leu-Leu-Glu beta-naphthylamide) were peptidyldiazomethanes containing hydrophobic amino acid residues. These results suggest that the original nomenclature of proteasome activities is misleading, because the residue in the P1 position is not the only determinant of specificity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280057      PMCID: PMC1137740          DOI: 10.1042/bj2960601

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  Proteasomes: protein and gene structures.

Authors:  K Tanaka; T Tamura; T Yoshimura; A Ichihara
Journal:  New Biol       Date:  1992-03

2.  Properties of subunits of the multicatalytic proteinase complex revealed by the use of subunit-specific antibodies.

Authors:  A J Rivett; S T Sweeney
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

3.  Peptidyldiazomethanes. A novel mechanism of interaction with prolyl endopeptidase.

Authors:  S R Stone; D Rennex; P Wikstrom; E Shaw; J Hofsteenge
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

4.  The multicatalytic proteinase. Multiple proteolytic activities.

Authors:  A J Rivett
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

Review 5.  Cysteinyl proteinases and their selective inactivation.

Authors:  E Shaw
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1990

6.  Multicatalytic, high-Mr endopeptidase from postmortem human brain.

Authors:  J R McDermott; A M Gibson; A E Oakley; J A Biggins
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

7.  Peptidylglutamyl-peptide hydrolase activity of the multicatalytic proteinase complex: evidence for a new high-affinity site, analysis of cooperative kinetics, and the effect of manganese ions.

Authors:  H Djaballah; A J Rivett
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

8.  Regulation of the peptidylglutamyl-peptide hydrolyzing activity of the pituitary multicatalytic proteinase complex.

Authors:  M Orlowski; C Cardozo; M C Hidalgo; C Michaud
Journal:  Biochemistry       Date:  1991-06-18       Impact factor: 3.162

9.  Use of serine-protease inhibitors as probes for the different proteolytic activities of the rat liver multicatalytic proteinase complex.

Authors:  H Djaballah; J A Harness; P J Savory; A J Rivett
Journal:  Eur J Biochem       Date:  1992-10-15

10.  A 3,4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complex.

Authors:  C Cardozo; A Vinitsky; M C Hidalgo; C Michaud; M Orlowski
Journal:  Biochemistry       Date:  1992-08-18       Impact factor: 3.162

View more
  9 in total

1.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

Authors:  A K Nussbaum; T P Dick; W Keilholz; M Schirle; S Stevanović; K Dietz; W Heinemeyer; M Groll; D H Wolf; R Huber; H G Rammensee; H Schild
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 2.  Regulation of proteasome structure and function.

Authors:  A J Rivett; G G Mason; R Z Murray; J Reidlinger
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 3.  Antigen processing by proteasomes: insights into the molecular basis of crypticity.

Authors:  H Djaballah
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 4.  Catalytic components of proteasomes and the regulation of proteinase activity.

Authors:  A J Rivett; G G Mason; S Thomson; A M Pike; P J Savory; R Z Murray
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

5.  Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells.

Authors:  R C Gardner; S J Assinder; G Christie; G G Mason; R Markwell; H Wadsworth; M McLaughlin; R King; M C Chabot-Fletcher; J J Breton; D Allsop; A J Rivett
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

Review 6.  From bortezomib to other inhibitors of the proteasome and beyond.

Authors:  Daniela Buac; Min Shen; Sara Schmitt; Fathima Rani Kona; Rahul Deshmukh; Zhen Zhang; Christine Neslund-Dudas; Bharati Mitra; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Autoproteolytic activation of ThnT results in structural reorganization necessary for substrate binding and catalysis.

Authors:  Andrew R Buller; Jason W Labonte; Michael F Freeman; Nathan T Wright; Joel F Schildbach; Craig A Townsend
Journal:  J Mol Biol       Date:  2012-06-15       Impact factor: 5.469

8.  Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome.

Authors:  Wilfried Moreira; Sridhar Santhanakrishnan; Brian W Dymock; Thomas Dick
Journal:  Front Microbiol       Date:  2017-04-27       Impact factor: 5.640

9.  A Selective Irreversible Inhibitor of Furin Does Not Prevent Pseudomonas Aeruginosa Exotoxin A-Induced Airway Epithelial Cytotoxicity.

Authors:  Timothy E G Ferguson; James A Reihill; Brian Walker; Robert A Hamilton; S Lorraine Martin
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.